These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30240941)

  • 21. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay.
    Lima V; Harrigan R; Montaner JS
    J Acquir Immune Defic Syndr; 2009 May; 51(1):3-6. PubMed ID: 19247185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.
    Garrett NJ; Apea V; Nori A; Ushiro-Lumb I; Oliver AR; Baily G; Clark DA
    J Clin Virol; 2012 Apr; 53(4):354-5. PubMed ID: 22261125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study.
    Pham MD; Haile BA; Azwa I; Kamarulzaman A; Raman N; Saeidi A; Kahar Bador M; Tan M; Zhu J; Feng Y; Elliott JH; Garcia ML; Li F; Crowe SM; Luchters S; Anderson DA
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30700508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece.
    Katsoulidou A; Rokka C; Issaris C; Haida C; Tzannis K; Sypsa V; Detsika M; Paraskevis D; Hatzakis A
    Virol J; 2011 Jan; 8():10. PubMed ID: 21219667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance Evaluation of the Bioneer AccuPower® HIV-1 Quantitative RT-PCR kit: Comparison with the Roche COBAS® AmpliPrep/COBAS TaqMan® HIV-1 Test Ver.2.0 for Quantification of HIV-1 Viral Load in Indonesia.
    Kosasih AS; Sugiarto C; Hayuanta HH; Juhaendi R; Setiawan L
    Asian Pac J Allergy Immunol; 2018 Jun; 36(2):120-125. PubMed ID: 28802027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification.
    Lima VD; Wang L; Brumme C; Wu L; Montaner JS; Harrigan PR
    PLoS One; 2017; 12(2):e0171155. PubMed ID: 28152073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New design, development, and optimization of an in-house quantitative TaqMan Real-time PCR assay for HIV-1 viral load measurement.
    Noorbazargan H; Nadji SA; Samiee SM; Paryan M; Mohammadi-Yeganeh S
    HIV Clin Trials; 2018 Apr; 19(2):61-68. PubMed ID: 29473487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Simple Phosphate-Buffered-Saline-Based Extraction Method Improves Specificity of HIV Viral Load Monitoring Using Dried Blood Spots.
    Makadzange AT; Boyd FK; Chimukangara B; Masimirembwa C; Katzenstein D; Ndhlovu CE
    J Clin Microbiol; 2017 Jul; 55(7):2172-2179. PubMed ID: 28468852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the performance of the Cepheid Xpert HIV-1 Viral Load Assay for quantitative and diagnostic uses.
    Wesolowski L; Fowler W; Luo W; Sullivan V; Masciotra S; Smith T; Rossetti R; Delaney K; Oraka E; Chavez P; Ethridge S; Switzer WM; Owen SM
    J Clin Virol; 2020 Jan; 122():104214. PubMed ID: 31835210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load.
    Mor O; Gozlan Y; Wax M; Mileguir F; Rakovsky A; Noy B; Mendelson E; Levy I
    J Clin Microbiol; 2015 Nov; 53(11):3458-65. PubMed ID: 26292298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-site clinical evaluation of the Xpert(®) HIV-1 viral load assay.
    Jordan JA; Plantier JC; Templeton K; Wu AH
    J Clin Virol; 2016 Jul; 80():27-32. PubMed ID: 27135387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5.
    Manavi K
    HIV Clin Trials; 2008; 9(4):283-6. PubMed ID: 18753122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay.
    Andreotti M; Pirillo M; Guidotti G; Ceffa S; Paturzo G; Germano P; Luhanga R; Chimwaza D; Mancini MG; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Clin Virol; 2010 Jan; 47(1):4-7. PubMed ID: 19962936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
    Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
    J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials.
    White K; Garner W; Wei L; Eron JJ; Zhong L; Miller MD; Martin H; Plummer A; Tran-Muchowski C; Lindstrom K; Porter J; Piontkowsky D; Light A; Reiske H; Quirk E
    AIDS; 2018 May; 32(8):1053-1057. PubMed ID: 29424783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.